SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is rallying fiercely as escalating geopolitical tensions, particularly concerning the Strait of Hormuz, drive strong momentum and intense community discussion about a massive short and gamma squeeze in this low-float energy stock.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is a hot topic following its Q4 earnings report, which featured increased revenue and substantial contracted commitments, alongside new partnerships with major European carriers like Orange and Telefonica for direct-to-device satellite connectivity. Community sentiment is sharply divided, with strong long-term conviction from bulls who see cutting-edge technology and defense potential, contrasting with bears focused on valuation concerns and past launch delays.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group (GRRR) is trending following strong FY2025 results, featuring record revenue and improved profitability, with the community actively debating its severe undervaluation compared to peers like BBAI. Enthusiasm is further fueled by strategic moves into non-dilutive project financing and new partnerships in the Middle East for large-scale AI infrastructure.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is trending sharply lower following its latest earnings report, where strong quarterly results were overshadowed by mixed guidance and news of key leadership departures, fueling community concerns over growth deceleration. Despite the 'brutality' of the drop, investors are divided, with some seeing a long-term buying opportunity and others anticipating further declines to fill a perceived price gap, reflecting broader software sector weakness.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy is trending as escalating Middle East tensions, including Iran's threats to close the Strait of Hormuz and attacks on oil infrastructure, drive expectations for surging crude prices. The community is actively discussing its potential for a substantial rally, drawing parallels to past energy spikes, despite some frustration over its relative performance compared to sector peers and concerns about dilution.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending due to recent milestones, including achieving 100% FAA Means of Compliance acceptance for its Midnight aircraft, which bulls highlight as a significant derisking event for its path to 2026 commercial operations. While Q4 results showed deeper losses, strong liquidity and new defense and Starlink partnerships are fueling community debate, contrasting regulatory progress with continued cash burn in the evolving eVTOL sector.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending after its Q3 earnings report, which, despite beating estimates, triggered a sharp after-hours sell-off due to market interpretation of conservative Q4 sales guidance. Community sentiment is split, with many highlighting strong fundamentals and massive AI infrastructure spending as reasons to buy the dip, while others remain cautious given previous volatility and concerns about valuation.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is trending as CEO Anthony Noto's recent open market share purchase signals strong management confidence, fueling investor optimism and renewed speculation around a potential S&P 500 inclusion. The community widely views this as a significant bullish catalyst, anticipating a positive impact on the stock.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending following its strategic acquisition of StereoLabs, which combines high-resolution digital lidar with AI vision and perception software to establish a unified Physical AI platform. This move, coupled with recent strong quarterly earnings showcasing impressive gross margins and a reinforcing path to profitability, has sparked bullish community discussion regarding the company's leadership in robotics, industrial automation, and autonomous systems.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to significant institutional accumulation and growing speculation that its photonic technology is critical for major hyperscalers, validated by the broader industry's embrace of advanced optics for AI data centers. The community is eagerly awaiting substantial commercialization updates and new partnerships expected around the upcoming industry conference.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Equities Analysts Issue Forecasts for ENTA Q2 Earnings

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Free Report) - Research analysts at HC Wainwright raised their Q2 2026 EPS estimates for Enanta Pharmaceuticals in a report released on Tuesday, February...

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of +21.50% and +19.52%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Enanta Pharmaceuticals (NASDAQ:ENTA) Posts Earnings Results, Beats Estimates By $0.12 EPS

Enanta Pharmaceuticals (NASDAQ:ENTA - Get Free Report) posted its earnings results on Monday. The biotechnology company reported ($0.42) earnings per share for the quarter, beating the consensus...

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat...

Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological...

Agios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?

Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm...

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

Enanta Pharmaceuticals (ENTA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Current Price	$14.51
Prev Close	$14.30
Open	$14.02
Dividend Yield	0.00%
50-Day Moving Average	$13.99
Beta	1.05
Avg. Volume	247,257.80
PE Ratio	-4.46

52-Week High	$17.15
52-Week Low	$4.09
Market Capitalization	$414.98M
EPS (Annual)	-$3.84
Price to Book	3.28
Revenue Per Employee	$544,366.67

ENTA
Enanta Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ENTA News

ENTAEnanta Pharmaceuticals Inc